711 related articles for article (PubMed ID: 21109517)
1. Long-term patient survival in ANCA-associated vasculitis.
Flossmann O; Berden A; de Groot K; Hagen C; Harper L; Heijl C; Höglund P; Jayne D; Luqmani R; Mahr A; Mukhtyar C; Pusey C; Rasmussen N; Stegeman C; Walsh M; Westman K;
Ann Rheum Dis; 2011 Mar; 70(3):488-94. PubMed ID: 21109517
[TBL] [Abstract][Full Text] [Related]
2. [Anti-neutrophil cytoplasmic antibody-associated vasculitis. Clinical aspects and treatment].
Paolini MV; Ruffino JP; Fernández Romero DS
Medicina (B Aires); 2013; 73(2):119-26. PubMed ID: 23570759
[TBL] [Abstract][Full Text] [Related]
3. Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab.
Stasi R; Stipa E; Del Poeta G; Amadori S; Newland AC; Provan D
Rheumatology (Oxford); 2006 Nov; 45(11):1432-6. PubMed ID: 16632482
[TBL] [Abstract][Full Text] [Related]
4. Off-trial evaluation of the B cell-targeting treatment in the refractory cases of antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis: long-term follow-up from a single centre.
Pullerits R; Ljevak M; Vikgren J; Bokarewa M
Scand J Immunol; 2012 Oct; 76(4):411-20. PubMed ID: 22823472
[TBL] [Abstract][Full Text] [Related]
5. Brief Report: long-term outcome of a randomized clinical trial comparing methotrexate to cyclophosphamide for remission induction in early systemic antineutrophil cytoplasmic antibody-associated vasculitis.
Faurschou M; Westman K; Rasmussen N; de Groot K; Flossmann O; Höglund P; Jayne DR;
Arthritis Rheum; 2012 Oct; 64(10):3472-7. PubMed ID: 22614882
[TBL] [Abstract][Full Text] [Related]
6. Ocular manifestations of ANCA-associated vasculitis.
Kubal AA; Perez VL
Rheum Dis Clin North Am; 2010 Aug; 36(3):573-86. PubMed ID: 20688251
[TBL] [Abstract][Full Text] [Related]
7. Treatment of antineutrophil cytoplasmic antibody-associated vasculitis.
Rich EN; Brown KK
Curr Opin Pulm Med; 2012 Sep; 18(5):447-54. PubMed ID: 22854508
[TBL] [Abstract][Full Text] [Related]
8. ANCA-associated vasculitis with renal involvement: an outcome analysis.
Weidner S; Geuss S; Hafezi-Rachti S; Wonka A; Rupprecht HD
Nephrol Dial Transplant; 2004 Jun; 19(6):1403-11. PubMed ID: 15069175
[TBL] [Abstract][Full Text] [Related]
9. A retrospective study on outcome of microscopic polyangiitis in chronic renal replacement therapy.
Merino JL; Galeano C; Espejo B; Rivera M; Fernández-Lucas M; Caldés S; Plana MN; Letosa M; Teruel JL; Quereda C; Ortuño J
Nephrol Dial Transplant; 2011 Apr; 26(4):1360-6. PubMed ID: 20810451
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of ANCA associated systemic necrotizing vasculitides].
Guillevin L
Bull Acad Natl Med; 2008; 192(6):1175-87; discussion 1188. PubMed ID: 19235481
[TBL] [Abstract][Full Text] [Related]
11. The future of ANCA-associated vasculitis.
Holle JU; Wieczorek S; Gross WL
Rheum Dis Clin North Am; 2010 Aug; 36(3):609-21. PubMed ID: 20688253
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcome of severe alveolar haemorrhage in ANCA-associated vasculitis: a retrospective cohort study.
Hruskova Z; Casian AL; Konopasek P; Svobodova B; Frausova D; Lanska V; Tesar V; Jayne DR
Scand J Rheumatol; 2013; 42(3):211-4. PubMed ID: 23374071
[TBL] [Abstract][Full Text] [Related]
13. Long-term efficacy of remission-maintenance regimens for ANCA-associated vasculitides.
Terrier B; Pagnoux C; Perrodeau É; Karras A; Khouatra C; Aumaître O; Cohen P; Decaux O; Desmurs-Clavel H; Maurier F; Gobert P; Quémeneur T; Blanchard-Delaunay C; Bonnotte B; Carron PL; Daugas E; Ducret M; Godmer P; Hamidou M; Lidove O; Limal N; Puéchal X; Mouthon L; Ravaud P; Guillevin L;
Ann Rheum Dis; 2018 Aug; 77(8):1150-1156. PubMed ID: 29724729
[TBL] [Abstract][Full Text] [Related]
14. [ANCA-associated forms of vasculitis].
Helmchen U; Kneissler U; Prall F
Verh Dtsch Ges Pathol; 1996; 80():38-45. PubMed ID: 9065053
[TBL] [Abstract][Full Text] [Related]
15. Rituximab for induction and maintenance treatment of ANCA-associated vasculitides: a multicentre retrospective study on 80 patients.
Charles P; Néel A; Tieulié N; Hot A; Pugnet G; Decaux O; Marie I; Khellaf M; Kahn JE; Karras A; Ziza JM; Deligny C; Tchérakian C; Guillevin L;
Rheumatology (Oxford); 2014 Mar; 53(3):532-9. PubMed ID: 24282319
[TBL] [Abstract][Full Text] [Related]
16. Predictive value of antineutrophil cytoplasmic antibodies in small-vessel vasculitis.
Lurati-Ruiz F; Spertini F
J Rheumatol; 2005 Nov; 32(11):2167-72. PubMed ID: 16265696
[TBL] [Abstract][Full Text] [Related]
17. B-cell depleting agents for ANCA vasculitides: a new therapeutic approach.
Gómez-Puerta JA; Quintana LF; Stone JH; Ramos-Casals M; Bosch X
Autoimmun Rev; 2012 Jul; 11(9):646-52. PubMed ID: 22146313
[TBL] [Abstract][Full Text] [Related]
18. [Wegener's granulomatosis and microscopic polyangiitis].
Pagnoux C
Rev Prat; 2008 Mar; 58(5):522-32. PubMed ID: 18524109
[TBL] [Abstract][Full Text] [Related]
19. Anti-neutrophil cytoplasmic antibody-associated vasculitis with renal involvement: Analysis of 89 cases.
Caravaca-Fontán F; Yerovi E; Delgado-Yagu E M; Galeano C; Pampa-Saico S; Tenorio MT; Liaño F
Med Clin (Barc); 2017 Jan; 148(1):1-7. PubMed ID: 28196580
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcome and prognosis of anti-neutrophil cytoplasmic antibody-associated vasculitis in Japan.
Itabashi M; Takei T; Yabuki Y; Suzuki H; Ando M; Akamatsu M; Yamazaki M; Mitobe M; Watanabe Y; Mochizuki T; Nitta K
Nephron Clin Pract; 2010; 115(1):c21-7. PubMed ID: 20173346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
